1. Home
  2. SMC vs CRVS Comparison

SMC vs CRVS Comparison

Compare SMC & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMC
  • CRVS
  • Stock Information
  • Founded
  • SMC 2009
  • CRVS 2014
  • Country
  • SMC United States
  • CRVS United States
  • Employees
  • SMC N/A
  • CRVS N/A
  • Industry
  • SMC
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMC
  • CRVS Health Care
  • Exchange
  • SMC NYSE
  • CRVS Nasdaq
  • Market Cap
  • SMC 395.3M
  • CRVS 451.0M
  • IPO Year
  • SMC 2012
  • CRVS 2016
  • Fundamental
  • Price
  • SMC $36.14
  • CRVS $8.95
  • Analyst Decision
  • SMC
  • CRVS Buy
  • Analyst Count
  • SMC 0
  • CRVS 4
  • Target Price
  • SMC N/A
  • CRVS $10.83
  • AVG Volume (30 Days)
  • SMC 61.3K
  • CRVS 1.0M
  • Earning Date
  • SMC 11-12-2024
  • CRVS 11-12-2024
  • Dividend Yield
  • SMC N/A
  • CRVS N/A
  • EPS Growth
  • SMC N/A
  • CRVS N/A
  • EPS
  • SMC 6.54
  • CRVS N/A
  • Revenue
  • SMC $469,635,000.00
  • CRVS N/A
  • Revenue This Year
  • SMC N/A
  • CRVS N/A
  • Revenue Next Year
  • SMC N/A
  • CRVS N/A
  • P/E Ratio
  • SMC $5.45
  • CRVS N/A
  • Revenue Growth
  • SMC 21.75
  • CRVS N/A
  • 52 Week Low
  • SMC $15.56
  • CRVS $1.23
  • 52 Week High
  • SMC $40.75
  • CRVS $9.70
  • Technical
  • Relative Strength Index (RSI)
  • SMC 54.12
  • CRVS 70.45
  • Support Level
  • SMC $31.81
  • CRVS $7.91
  • Resistance Level
  • SMC $35.78
  • CRVS $9.70
  • Average True Range (ATR)
  • SMC 1.31
  • CRVS 0.75
  • MACD
  • SMC 0.08
  • CRVS -0.01
  • Stochastic Oscillator
  • SMC 86.91
  • CRVS 67.51

About SMC SUMMIT MIDSTREAM CORPORATION

Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, primarily shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: